Rep. Young Optimistic Following Expedited FDA Approval of Remdesivir to Treat COVID-19
April 30, 2020
April 30, 2020
WASHINGTON, April 30 -- Rep. Don Young, R-Alaska, issued the following news release:
Alaska Congressman Don Young expressed optimism following New York Times reports that the Food and Drug Administration (FDA) plans to announce emergency use authorization for Gilead Science's Remdesivir for use in COVID-19 patients. This week, Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci announced that patients who received Remdesivir had a 31 percent faster re . . .
Alaska Congressman Don Young expressed optimism following New York Times reports that the Food and Drug Administration (FDA) plans to announce emergency use authorization for Gilead Science's Remdesivir for use in COVID-19 patients. This week, Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci announced that patients who received Remdesivir had a 31 percent faster re . . .